SOPHARMA AD (22/2021) Notification from Ognian Donev under Art. 19 of Regulation (EU) No 596/2014 of 2 June 2021.
Report no 22/2021
- 03.06.2021, 09:24
- Kategoria: Biznes i finanse
- Źródło: ESPI
Sopharma AD-BG11SOSOBT18-SOPHARMA
-
-
SOPHARMA AD (21/2021) Notification from Ognian Donev under Art. 19 of Regulation (EU) No 596/2014 of 1 June 2021.
Report no 21/2021- 02.06.2021, 11:27
- Kategoria: Biznes i finanse
- Źródło: ESPI
-
SOPHARMA AD (20/2021) Annual General Meeting of Shareholders convened for 4 June 2021 from 11:00 a.m. (8:00 a.m. UTC)
Report no 20/2021- 01.06.2021, 13:02
- Kategoria: Biznes i finanse
- Źródło: ESPI
-
SOPHARMA AD (19/2021) Consolidated financial report according to IFRS as at 31 March 2021.
Report no 19/2021- 31.05.2021, 13:32
- Kategoria: Biznes i finanse
- Źródło: ESPI
-
SOPHARMA AD (18/2021) The Board of Directors of "Sopharma" AD adopted a decision to issue warrants
Report no 18/2021- 21.05.2021, 13:01
- Kategoria: Biznes i finanse
- Źródło: ESPI
-
SOPHARMA AD (17/2021) Sales revenues for April 2021
Report no 17/2021- 13.05.2021, 15:48
- Kategoria: Biznes i finanse
- Źródło: ESPI
-
SOPHARMA AD (16/2021) Individual financial report according to IFRS as at 31 March 2021.
Report no 16/2021- 29.04.2021, 11:40
- Kategoria: Biznes i finanse
- Źródło: ESPI
-
SOPHARMA AD (14/2020) Audited Consolidated Financial Statements of Sopharma Group for 2020
Report no 14/2020- 28.04.2021, 21:24
- Kategoria: Biznes i finanse
- Źródło: ESPI
-
SOPHARMA AD (13/2021) Sales revenues for March 2021
Report no 13/2021- 05.04.2021, 13:03
- Kategoria: Biznes i finanse
- Źródło: ESPI
